| Name | Title | Contact Details |
|---|---|---|
Kevin Hanson |
Vice President, Legal | Profile |
Kelli Wilson |
Senior Vice President Quality and Regulatory Compliance | Profile |
Teri Witteman |
General Counsel and Secretary | Profile |
Apio Inc. is one of the leading companies in the Manufacturing sector.
We would like to extend our most gracious welcome to The Grand Prospect Hall, located for more than a century in Brooklyns historic Park Slope. Here, youll take a magical journey into a fairytale era of utter opulence. Once, a wealthy and cosmopolita...
GPM Investments LLC is a convenience store owner and operator based in Richmond, Virginia.
The Specialty Food Association is a not-for-profit business trade association established in 1952 to foster trade, commerce and interest in the specialty food industry. The Specialty Food Association is an international organization composed of domestic and foreign manufacturers, importers, distributors, brokers, retailers, restaurateurs, caterers and others in the specialty foods business. The association is composed of 3,000+ independent & innovative businesses committed to bringing great foods to market throughout the U.S. and overseas. To foster a thriving specialty food marketplace. To be globally recognized as the innovative hub of the food and beverage industry.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.